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Summary.-Characteristics of the AKB6F1 mouse strain make it suitable as an assay
animal for quantitating haemopoietic stem cells, or spleen colony-forming units
(CFU-S), from leukaemic AKR mice. Marrow cells harvested from leukaemic mice
were assayed for CFU-S in lethally irradiated AKR or AKB6F1 hosts. Survival times
and numbers of leukaemic colony-forming units (L-CFU) in unirradiated recipients
were used to detect proliferation of transplanted leukaemic cells. In contrast to
AKR recipients, the proliferation of transplanted leukaemic cells was suppressed in
F1 hosts. Injection of marrow cells from normal nonleukaemic AKR mice into AKR
and F1 hosts yielded significantly more CFU-S and spleen 59Fe uptake in F1 than in
AKR hosts. In marked contrast, injection of marrow from leukaemic AKR mice
suppressed CFU-S proliferation in the F1 recipients. Thus it was possible to quanti-
tate CFU-S in marrow containing L-CFU.
AKR SPONTANEOUS and transplanted leu-
kaemias are often used to measure the
effects of anticancer agents on malignant
and normal cell populations (Bruce, et al.,
1966, 1969; Skipper et al., 1969; Schabel
et al., 1969). Prior work has determined
the growth characteristics and drug sensi-
tivity of the thymus-derived malignant
cells from leukaemic AKR mice (above
references, plus Zatz et al., 1973; Barker
& Waksal, 1974; Omine & Perry, 1972).
However, fewer studies have addressed
themselves to possible changes in the other
haemopoietic cell lines (Hays et al., 1976;
Chevalier et al., 1974; Frindel & Chevalier,
1975; Sainteny et al., 1977, 1978). One
reason for this is that, when transplanted
into irradiated syngeneic mice, leukaemic
cells and normal haemopoietic stem cells
give rise to spleen colonies that are
macroscopically similar (Bruce & Van der
Gaag, 1963). Furthermore, after marrow
transplantation, lethally irradiated AKR
mice fail to adequately support haemo-
poiesis (Legrand & Duplan, 1978; Perkins
et al., 1971). Normal haemopoietic stem
cells are less able to proliferate and differ-
entiate in the spleen and marrow of the
irradiated syngeneic AKR recipients
(Legrand & Duplan, 1978; Perkins et al.,
1971). Therefore, it has been difficult
to use the spleen colony-forming unit
(CFU-S) assay to measure the number
of pluripotential haemopoietic stem cells
in the tissues ofleukaemic AKR mice.
Characteristics of the (AKR x C57BL/
6)Fj mouse suggested that with this
mouse hybrid it might be feasible to use
the CFU-S assay to quantitate haemo-
poietic stem cells in tissues of leukaemic
AKR mice. Transplanted marrow cells
from nonleukaemic AKRmicewillprolifer-
ate and give rise to spleen colonies in
irradiated AKB6F1 mice (Trentin et al.,
1973, 1976). However, the proliferation of
transplanted leukaemic cells from leuk-
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aemic mice is suppressed (Trentin et al.,
1973, 1976). The results presented in the
present paper demonstrate that these F1
mice provide a valid means to detect
normal haemopoietic stem cells in the
marrow of AKR mice with both early and
late stages of spontaneous and first-
passage leukaemias. In addition, these
results show that haemopoietic precursors
are decreased or suppressed in the marrowAA
of AKR mice with spontaneous or first-
passage leukaemia.
MATERIALS AND METHOS)S
Mice.- The AKB6F1 or (AKR x C57BL/
6)F1 mice and male mice of the C57BL/6
parental strain were from a breeding colony
maintained in our laboratory. AKR/J mice
were purchased from Jackson Laboratories.
Bar Harbor, Maine.
Normal donor and recipient mice were 3-4
months old, and leukaemic donors wiere 7-10
months old. For experimental studies, the
mice were randomized into groups by age
and weight. Palpation of the spleen and the
inguinal lymph nodes was used to identify
leukaemic mice. After killing, mice that also
had an enlarged thymus ( > 200 mg) were
used for these studies. After irradiation and/
or cell transplantation, the mice wi-ere housed
5 per shoebox polypropylene cage on Sanicel
bedding, maintained in a laminar-flow hood.
and allowed food and HCl-acidified water
(pH 2.4) adlibituna.
Irradiation. Mice were whole-body irradi-
ated at a dose rate of 1 2 Gy/min by a
137Cs irradiator (Mark 1, Shepherd and
Associates, Glendale, California).
Preparation of cell suspensions. Mice were
killed by cervical dislocation, the tissues were
excised and weighed. and cells for injection
were flushed from the tissues with Hanks'
l)alanced salt solution (HBSS) and dispersed
through a 25-gauge needle. A ZBI Coulter
Counter was used to determine the number
of nucleated cells. The cell suspensions wvere
then diluted to the desired concentrations
for injection in 0(2 ml HBSS and injected
into a caudal vein of each mouse.
Spleen-colony and spleeni 59Fe-uptake
assay.s.-CFU-S determinations were done
basically as described by Till & McCullochl
(1961). Recipient AKR and AKB6F1 mice
were irradiated att 9 Gy and 9 5 Gy respec-
tively. Animals wvere injected with cells
within 2 h after irradiation. Seventeen hours
before the mice were killed for Day 8 spleen-
colony determinations, they wvere injected
ip. with 0-1 ,uCi 59Fe-ferrous citrate (Mallink-
rodt Nuclear) diluted in 0-2 ml of 0-003M
citrate. The individual spleens were counted
in a wvell-type scintillation counter (Nuclear
Chicago).
Unlike normal cells, leukaemic cells may
give rise to spleen colonies in unirradiated
mice (Bruce & Van der Gaag, 1963; Bruce
& Meeker. 1964). Thus, assays for leukaemic
colony-forming units (L-CFU) are used as
an estimate of the number of leukaemic cells
capable of proliferating int vivo (Bruce &
Van der Gaag, 1963; Bruce & Meeker, 1964).
Unirradiated 3-4-month-old mice were used
to assay for L-CFU in the marrow and thymus
from leukaemic AKR mice.
Marrow differential cell counts. Nucleated
cell counts were made on the marrow from a
humerus of individual mice, as described by
Chervenick et al. (1968). Samples containing
1-5 x 105 nucleated cells from the marrow
wash-outs wvere centrifuged on to serum-
coated (FCS-Gibco) slides using a cyto-
centrifuge (Shandon Eliot) at 800 rev/min
for 5 min. The numbers of neutrophils and
neutrophil precursors per humerus were
determined using a modification of a staining
method usinga peroxidasereaction (Rytomaa.
1962). The number of neutrophilic cells was
calculated by multiplying the number of
nucleated cells per humerus by the propor-
tion of peroxidase+ (brown to yellow) cells
in a 400 cell count on the treated
slides.
First-pacssaqe leukaentias. These were ini-
tiated in 3-4-month-old normal AKR mice
l,y i.v. injections of 106 cells from the thymus
or marrow of AKR mice with spontaneous
leukaemia.
Statistics. Cell counts and spleen colony
counts tend to be skewed (Smith et al.. 1954)
so the geometric means wiere used to obtain
a more normal distribution of the variables
(Sokal & Rohlf. 1969). Zero colony, counts
wA-ere included in the geometric means. as
described by Smith et al. (1966). The wN-eighted
means (± s.e.) wvere used to combine data
from similar experiments (Sokal & Rohlf,
1969: Smith et al.. 1966). The t test was used
to define significant differences between
groups ofmice.
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RESULTS
Growth of marrow stem cells from non-
leukaemic AKR mice in irradiated AKR
andAKB6F1 recipients
Background levels in the irradiated
controls are similar for AKR mice given
9 Gy and AKB6F1 mice given 9-5 Gy
y-irradiation. The average number of
colonies per spleen was less than 1, and
the percentage of injected 59Fe per spleen
was about 0.3%. Both of these measure-
ments were higher in the recipients of
transplanted marrow cells (Fig. 1). AKR
recipients had a mean of 45 + 1-77
colonies per spleen, which is significantly
lower (P < 0.01) than the 13-5 + 3-36 colon-
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FIG. 1. Growth of marrow stem cells from
nonleukaemic AKR mice in irradiated
AKR and AKB6F1 mice. In individual
studies, 105 nucleated cells pooled from the
marrow of 5 iionleukaemic AKR mice (3-
4-month-old females) given 9 Gy ( 1.)and
AKB6F1 mice giveni 9-5 Cy (C). The geo-
metric mean number of colonies and per-
centage of injected 59Fe uptake per spleen
were measured 8 days after irradiation and
cell injections. Results shown the totals
from 4 experiments totalling 50 mice.
Bars indicate s.e.
60
ies per spleen in the F1 mice. The per-
centage of injected 59Fe uptake per spleen
was also significantly higher (P<0.01)
in the F1 (2.1 + 0.44) than the AKR
(0-8 + 0.07) recipients. Thus the F1 mouse
appears to be more sensitive than the
AKR mouse in the detection of possible
decreases in the number of CFU-S in the
marrow of AKR mice with early, late, or
terminal stages ofleukaemia.
Survival ofAKR mice after transplantation
of cellsfrom leukaemic AKR mice
Irradiated AKR and F1 mice were
injected with 102, 103, or 104 cells pooled
from the thymuses of 5 AKR mice with
spontaneous leukaemia. For these cell
doses, there was no evidence of prolifera-
tion of transplanted leukaemic cells in the
spleens ofeither the AKR or F1 recipients.
Eight days later, in all groups, the mean
number of colonies per spleen was < 1,
and the spleen weights were not signifi-
cantly greater than for the irradiated
control recipients AKR (23 mg ± 2) or
F1 (21 mg+ 1). However, the deaths of
unirradiated AKR recipients proved that
the cell suspensions contained leukaemic
cells capable of proliferating tn vtvo.
Twenty to 100% of the AKR mice died
with evidence of leukaemia within 20-89
TABLEI.-Survival of AKR and AKB6F1
mice after transplantation of cells from
leukaemic AKR mice
Donor Cells
cells* injected
Thymus 102
103
Thymus 103
104
Marrow 106
Recipients deaths
mice injected
(Mean survival in days)
AKR AKB6F1
2/10 (71 + 18) 0/10
5/10 (53 + 4) 1/lot
9/9 (36 + 4) 0/10
10/10 (42+ 3) 1/10 (55)
10/10 (27 + 1) 1/34 (35)
* 3-4-month-old unirradiated female AKR and
AKB6F1 mice were injected with cells from the
thymuses or marrows of 8-9-month-old female AKR
mice with spontaneous leukaemia. Equal numbers
ofnucleated cells were pooled from 5 donor mice and
the samples were then serially diluted for cell
injections.
t Nonleukaemic death.
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TABLEII.-Proliferation of transplanted leukaemic cells in spleens of unirradiated AKR
and AKB6F1 Mice
Unirradiated recipientst
_ s A~~~~
Donor cells*
1 None
2 Thymus (103)
3 Thymus (103)
4 Marrow
5 Marrow
6 Marrow
7 Marrow
8 Marrow
Colonies/S
AKR
0
2-0+1-5
Confluent§
Confluent
Confluent
Confluent
Confluent
Confluent
spleen., Spleen weight (mg) ~~~~A
AKB6F1 AKR AKB6F1
0 80+4 80+2
0 98+10 87+6
9 2+6 5 372+25 91+4
0-1+0-2 115+6 102+15
0 132+12 65+4
1-0+0-8 168+9 68+3
3 6+3 8 211+10 81+9
0-1+0-2 115+6 102+5
*Equal numbers of cells were pooled from the thymuses of 5 AKR mice with spontaneous leukaemia
(Groups 2 and 3). Cells from 1% of humerus from quantitative marrow washout, pooled from 5 AKR mice
with spontaneous leukaemia (Group 4). Cells in 1% of humerus from quantitative marrow washout from
individual AKR mice with spontaneous leukaemia (Groups 5, 6, 7, and 8).
t12-16-week-old AKR or AKB6F1 females. The values represent the means+ s.e. of 5 mice.
Geometric means.
§ Or > 50 colonies.
days after the injection 102, 103, 104, or
106 cells (Table I). Only 2/74 (% 3°%) ofthe
F1 mice died with evidence of leukaemia
(enlarged spleen and/orthymus), andthese
2 received the largest cell doses.
These studies demonstrated that F1
mice are able to suppress the growth of
transplanted leukaemic cells. However,
this resistance, as measured by survival,
may be broken by the injection of suffi-
cient leukaemic cells. The total number of
cells necessary to overcome this resistance
depends on the degree of infiltration of
the donor tissues by clonogenic leukaemic
cells. This may be different for each
mouse, due to variability in characteristics
of AKR mice with overt evidence of
spontaneous leukaemia.
L-CFU as a measure of proliferation of
transplanted lymphomacells
The spleens ofunirradiated AKR recipi-
ents of cells from each of the leukaemic
donors were enlarged (Table II). The
spleens were also whitish, and some had a
mottled appearance with no distinct
colonies, while others had >50 over-
lapping colonies. Both types of spleen
were designated as having confluent
colonies. In contrast, the spleen weights
of the unirradiated F1 recipients were
within the range (80 + 2 mg) measured in
untransplanted F1 mice, and in most cases
the mean number of colonies per spleen
was < 1. Colonies were seen on some
spleens (1-8 per spleen), and in 2 cases
(donors 3 and 7) there was a significant
number of colonies from leukaemic cells.
However, compared to AKR recipients,
the proliferation of transplanted L-CFU
was suppressed in the spleens of unirradi-
ted F1 mice. Cells equivalent to 1% of a
humerus (5 x 104 to 5 x 105 nucleated
cells) were injected into irradiated recipi-
ents to assay for CFU-S. Table II demon-
strates that the proliferation of L-CFU
contained in 1% of a humerus of AKR
mice with spontaneous leukaemia is sup-
pressed in the spleens of unirradiated F1
mice.
CFU-S in irradiated recipients of marrow
fromAKKR mice withspontaneous leukaemia
Cells from the same leukaemic donors
as in Table II were also injected into
irradiated AKR and F1 mice. As seen in
the unirradiated AKR mice, the spleens
of the irradiated AKR recipients of cells
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TABLE III.-Spleen colony-forming units in irradiated recipients of cells from marrow
of AKR mice with spontaneous leukaemia
Irradiated recipientst
Donor eells*
1 None (10)
2 Normal (10)
4
5
6
7
8
Number ofcells
injeeted
0
9X 104
7 x 104
5 x 104
1 x 105
7 x 104
6x 104
A
Colonies/Spleent Spleen weight (mg)
AKR AKB6F1 AKR AKB6F,
0 0 20+1 24+2
4-1+1-4 10-3+1-8 20+1 27+1
Confluent§ 0-5+0 3 25+ 2 25+1
Confluent 2 - 6+ 0-4 65+ 7 23+1
Confluent 0-9 + 0-4 103+ 8 25+ 3
Confluent 0 211+10 23+2
Confluent 0-5+0-3 25+ 2 25+1
*Equal numbers of cells pooled from quantitative marrow washouts of 5 nonleukaemic (3-4-month-old)
AKR or 8-9-month-old AKR mice with spontaneous leukaemia(Group 2). Numbers 4-8 are same donors
as in Table II.
t 3-4-month-old mice. AKR were given 9 Gy and AKB6F1 9-5 Gy. 5-10 mice/group.
t Geometric mean.
§ > 50 colonies.
from the marrow of AKR mice with
spontaneous leukaemia had a mottled
appearance or >50 colonies (Table III).
In all but one example (Donor 5) the
mean number of colonies per spleen ofthe
F1 mice was close to the background
levels (0) in mice ofthe irradiated controls
(no cells). These values were also signifi-
cantly lower (P<0-0001) than the 10-3+
1-81 colonies seen on the spleens of F1
recipients of cells from 1% of a humerus
of 3-4-month-old nonleukaemic AKR
mice.
Spleen 59Fe uptake was also lower in
recipients of cells from the marrow of
leukaemic AKR mice. F1 recipients of
cells from donors of Group 4 (Table III)
had a mean uptake of only 0-5+0-1%;
not much higher than the 0-3+0.0%
seen in the irradiated controls. The data
summarized in Table III suggest that the
numberandconcentrationofnonleukaemic
haemopoietic stem cells were decreased
in the marrow of AKR mice with spon-
taneous leukaemia.
CFU-S in marrow of AKR mice withfirst-
passage leukaemia
Irradiated AKB6F1 mice were used to
assay for the number of nonleukaemic
haemopoietic stem cells in the marrow of
AKR mice with early and late stages of
first-passage leukaemia. Four first-
passage leukaemias were initiated in AKR
mice by the injection of cells pooled from
the thymus or marrow of AKR mice with
spontaneous leukaemia. Five to 9 and 12-
15 days later, the animals were killed.
Marrow from the humeruses of 5 mice
were pooled, and 105 cells were injected
TABLE IV.-Tissue weights and marrow cell counts of AKR mice with first-passage
leukaemia*
Cells/Humerus
Mice Spleen weight (mg) Thymus weight (mg) Total (x 10-3)t % Peroxidaset
Day 5
Normal
Leukaemic
Day 14
Normal
Leukaemic
81+6
91+5
86+4
522 + 31
97+6
104 + 6
132 + 10
123 + 18
9369+ 449 53-3+ 4-9
10151 + 556 56-6+ 3-1
9240+ 537
7461 + 411
52-0+ 1-5
6-1+0-6
* 3-4-month-old AKR mice were injected i.v. with 105 cells from the thymus of an AKR mouse with
spontaneous leukaemia, and died within , 16 days.
t Geometric means.
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into unirradiated 3-4-month-old AKR
mice. The death of these recipients
established the presence of leukaemic
cells in the marrow of the mice with first-
passage leukaemia. Cells were also injected
into irradiated F1 mice, and 8 days later
the number of colonies and the percentage
of injected 59Fe were determined.
Changes in tissue weights and marrow
cell counts were similar in mice from all
4 of the transplanted leukaemias (Table
IV). The spleen and thymus weights of
AKR mice with early (Day 5) stages of
leukaemia were not significantly different
(P > 0.05) from those of the nonleukaemic
controls. Mice with terminal stages (Day
14) ofthedisease hadveryenlarged spleens.
The number of cells and the percentage of
peroxidase+ cells in the humeruses of mice
with early stages of leukaemia were not
significantly different (P > 0.05) from those
of the nonleukaemic mice. However,
AKR recipients died within 90 days, thus
demonstrating the presence of some leuk-
aemic cells in the marrow at this time.
Mice with late stages of leukaemia had a
somewhat, but not significantly, lower
(0 025 <P < 0.05) number of cells per
humerus. In contrast, the percentage, and
thus the number, of peroxidase+ cells per
humerus was greatly reduced in the
leukaemic mice (Table IV).
The percentage of 59Fe uptake in
spleens of the F1 recipients of cells from
the marrow of mice with early and late
stages of this first-passage leukaemia is
illustrated in Fig. 2. These measurements
were not signicantly different in recipients
of cells from the nonleukaemic donors and
from mice withDay 5leukaemia. However,
59Fe uptake was only 0.4% in recipients
of cells from donor mice with late stages
of the disease. This approximated to the
irradiated controls, and was significantly
lower than the 2.2% measured in recip-
ients of cells from nonleukaemic mice.
For this and the other transplanted
leukaemias studied, the haemopoietic pre-
cursors were decreased or suppressed in
the marrow of AKR mice with late stages
ofthe disease.
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FIG. 2.-Percentage of injected 59Fe uptake
per spleen as a measure of levels of pluri-
potent haemopoietic stem cells from mar-
rows of AKR mice with early and late
stages of first-passage leukaemia. AKR
mice wereinjected i.v. with 105 cells from
the thymus of an AKR mouse with spon-
taneous leukaemia. Five and 14 days later,
105 nucleated cells pooled from the marrow
of 5 leukaemic (a) or nonleukaemic mice
(I) were injected into AKB6F1 mice
given 9-5 Gy. Controls (iii) received irradia-
tion alone. The percentage of injected 59Fe
uptake per spleen was determined 8 days
later. Values are the mean+s.e. of 10 mice
per group.
The number of colonies per spleen of
F1 recipients of cells from mice with early
stages of leukaemia was not significantly
different (P > 0.05) from that of the non-
leukaemic AKR mice. In addition, the
20 + 7*8 colonies per spleen of recipients
of cells from mice with late stages of the
disease was not significantly different than
the 19 + 1-7 colonies on the spleens of the
recipients of cells from the marrow of
nonleukaemic AKR mice. This was sim-
ilar for the other first-passage leukaemias
studied, in that the number of colonies
was somewhat higher or about the same
on spleens from the leukaemic mice as on
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spleens of recipients of cells from non-
leukaemic donors.
DISCUSSION
The objectives of the present report
were to expand the studies described by
Trentin et al. (1976) and to evaluate the
usefulness of the (AKR x C57B1/6)Fl
mouse as a tool to discriminate between
leukaemic and nonleukaemic haemopoietic
stem cells in the marrow of AKR mice.
The proliferation of leukaemic colony-
forming units (L-CFU) was suppressed
in the spleens of F1 recipients of cells
from leukaemic AKR mice. The present
studies demonstrated that the spleens of
F1 mice were capable of resisting the
growth of the number of L-CFU found in
10% of hutmerus (5 x 104-5 x 105 nucleated
cells) from AKR mice with spontaneous
leukaemia. Normal haemopoietic stem
cells are less able to proliferate and differ-
entiate in the spleen and marrow of
irradiated syngeneic recipients (Legrand
& Duplan, 1978; Perkins et al., 1971).
However, from the data presented in this
paper, the F1 mouse appears to provide a
suitable haemopoietic microenvironment
for the proliferation and subsequent
differentiation of nonleukaemic haemo-
poietic stem cells from AKR mice. Thus,
the F1 mouse may be a more sensitive
assay animal than the AKR inouse to
detect possible decreases in the number of
CFU-S in the marrow of AKR mice with
early, late or terminal stages ofleukaemia.
The growth and development of paren-
tal marrow and lymphoid grafts are
inhibited in certain F1 mouse hybrid
combinations (Snell & Stimpfin, 1966;
Cudkowicz & Bennett, 1.971; Cudkowicz
& Lotzova, 1973; Bennett, 1972; Cud-
kowicz, 1968). This resistance is directed
at Hh (Hybrid-histocompatibility or
haemopoietic histocompatibility) antigens
(Cudkowicz, 1968; Bennett, 1972). In
some mouse strains the Hh antigens are
expressed on both normal and leukaemic
haemopoietic and lymphoid cells (Cud-
kowicz, 1968; Iorio et al., 1978). However,
in other strains such as the AKR mouse,
these antigens appear to be expressed
only on the leukaemic cells (Trentin et al.,
1973; 1976; Jorio et al., 1978). Also, the
resistance of the F1 mouse can be abro-
gated by the injection of a large number
of cells, and in the marrow with lower
cell numbers than in the spleen (Trentin
etal., 1976).
Other investigators pretreated cell sus-
pensions from leukaemic AKR mice with
anti-6 serum plus complement, and the
remaining cells were injected into irradia-
ted syngeneic mice to assay for CFU-S
(Chevalier, 1974; Sainteny et al., 1977,
1978). Neither the number of leukaemic
cells nor the total number of cells elimin-
ated by this procedure was determined.
Anti-0 serum is capable of eliminating all
cells bearing the 0-antigen surface mole-
cule, whether leukaemic or nonleukaemic.
Some populations of T cells in mice and
humans may influence the differentiation
responses of haemopoietic stem cells
(Goodman et al., 1978; Resnitisky et al.,
1971; Nathan et al., 1978; Wiktor-
Jedrzejczak et al., 1977) and in mice small
numbers ofthese cells exist in the marrow,
spleen, and thymus (Wiktor-Jedrzejczak
et al., 1977). With the AKB6F1 mouse it is
possible to flush cells from the tissues of
AKR mice and, without pretreatment to
remove the leukaemic cells, they can be
injected into the irradiated recipients to
assay for CFU-S and the subsequent
differentiation of these stem cells. Some
of the same cell suspensions can also be
injected into unirradiated AKR mice to
assay for L-CFU.
Results presented in this paper demon-
strate that AKB6F1 mice can be used to
assay for CFU-S in the marrow of AKR
mice with spontaneous or first-passage
leukaemia. As seen by colony number
and spleen 59Fe uptake in irradiated mice,
the number and concentration of CFU-S
in the marrow of AKR mice with spon-
taneous leukaemia was significantly less
than in nonleukaemic mice. A decrease in
the concentration of CFU-S in the non-
leukaemic cell population was also demon-
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strated by other investigators, using the
anti-O+ complement protocol (Frindel &
Chevalier, 1975). Our studies of the mar-
row of AKR mice with first-passage leuk-
aemias gave somewhat different results
from those seen in mice with spontaneous
leukaemia. AKB6F1 recipients of cells
from mice with late stages of the disease
hod low spleen 59Fe uptake, and the same
number or slightly more spleen colonies.
This apparent discrepancy may be because
someofthe coloniesmayhavebeen derived
from the proliferation of leukaemic cells.
Compared to AKR mice with spontaneous
leukaemia, mice with first-passage or
long-passaged leukaemia may have a
higher proportion ofL-CFU in the marrow
(Bruce & Van der Gaag, 1963; Schwartz,
1980). The evidence for fewer neutro-
phils in the marrow ofthe leukaemic mice
also suggests that CFU-S may be reduced.
Alternatively, the colonies may have
been derived from CFU-S that were
unresponsive to normal stimulation for
erythropoietic differentiation (Goodman
et al., 1978; Wiktor-Jedrzejczak et al.,
1977).
The limitations of the AKB6F1 assay
system are determined by the number of
leukaemic cells and the corresponding
decrease in the normal cell populations.
Spleen colony numbers are a good quanti-
tative assay for CFU-S in the range of
5x 104 to 5 x 105 injected cells from the
marrow of normal mice (Smith, 1964).
If the concentration of CFU-S were
decreased, it would be necessary to inject
more cells. However, the injection of
more cells from the leukaemic mice is not
always feasible, since a larger number of
leukaemic cells would also be injected,
and might then give rise to leukaemic
colonies. The sensitivity of this AKB6F1
assay system could be enhanced by the
removal of leukaemic cells by techniques
such as velocity sedimentation or counter-
flow centrifugation. Also, it would be
possible to differentiate between colonies
derived from CFU-S and L-CFU. Cells or
individual colonies from the spleens of
the AKB6F1 recipients could be injected
into nonleukaemic AKR mice. If these
mice die with leukaemia within 90 days
(Schabel et al., 1969), some ofthe injected
cells were leukaemic. The presence of an
AKR subline, AKR(Rb6.15)1Ald, makes
it feasible to use cytogenetic analysis as
another means of determining whether
the colonies are derived from transplanted
leukaemic cells or host nonleukaemic
haemopoietic stem cells. Along with in
vivo and in vitro clonal assays for CFU-S,
BFU-E, CFU-E, and GM-CFU, the
AKB6F1 mouse may be useful in studies
to determine the mechanisms that regulate
the haemopoietic stem-cell compartments
during the development or treatment of
leukaemia in AKR mice.
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